GLS and neoplasm: Inhibits GLS and regulates glutamine metabolism thereby affecting the TCA cycle; BAG3 inhibits the formation of the GLS-SIRT5 complex and prevents proteasomal degradation of GLS, thereby promoting autophagy; activates SOD1 and promote tumour growth (136–140)